PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy

Stem Cells - United States
doi 10.1002/stem.2929
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Brca2Deficiency Sensitizes Cells to PARP Inhibition

Cancer Research
Cancer ResearchOncology
2006English

PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Reduced PAK1 Activity Sensitizes FA/BRCA-proficient Breast Cancer Cells to PARP Inhibition

Oncotarget
Oncology
2016English

Simultaneous Activation and Inhibition of Autophagy Sensitizes Cancer Cells to Chemotherapy

Oncotarget
Oncology
2016English

Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab

International Journal of Cancer
Cancer ResearchOncology
2019English

Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab

International Journal of Cancer
Cancer ResearchOncology
2018English

ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status

Cancer Research
Cancer ResearchOncology
2013English

Genistein Sensitizes Cancer Cells to Chemotherapy: Table 1.

Cancer Research
Cancer ResearchOncology
2005English

Tubeimoside-I Sensitizes Colorectal Cancer Cells to Chemotherapy by Inducing ROS-mediated Impaired Autophagolysosomes Accumulation

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy